Cell Phone-Enabled Diagnostics: mHealth Applications in IVD


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

  1. 1. Cell Phone-Enabled Diagnostics: mHealth Applications in IVDReport Details:Published:August 2012No. of Pages: 130Price: Single User License – US$2500Mobile health has reached in vitro diagnostics and as this Kalorama report details, may changethe industry forever. Over the years, the introduction of transportable, portable, and handheldinstruments has resulted in the migration of clinical lab testing from the central lab to a range ofenvironments including self-testing, community clinics, the workplace, home, disaster care andmost recently, retail convenience clinics. In spite of promotional materials that emphasize ease ofuse, the majority of currently available POC tests require a fair amount of medical lab know-how,especially in the interpretation of the test result.The goal is for cell phone-enabled test devices to provide primary care for underserved areas indeveloped countries and low income developing markets. Especially since new technologies areallowing POC devices to produce quantitative lab-quality test results that can be transferredautomatically to an information system, to a remote caregiver service for consultation or to anelectronic medical record.This report, Cell Phone-Enabled Diagnostics: mHealth Applications in IVD tracks cell phone-enabled products on the market and how they will affect the existing diagnostic industry. As partof this reports coverage, the following is included:•Representative Cell Phone-Enabled Products in Diabetes, Immunoassays, Hematology, Histology and Molecular IVD.•Market Outlook for mHealth In IVD and The Best Areas For Commercial Success•Description of the Market Leaders, Organizations and Companies In This Market.•Government and Payer Support for mHealth•The Role of New technologies in the Evolution of POCT•Consumer, Physician and Payor Willingness•How Upstarts are Faring Vs. Established Products•Analyst ConclusionsKalorama lead diagnostic analyst Shara Rosen, R.T., MBA presents the new developments in theconvergence of IVD and mobile technologies in this unique overview of the mHealth IVD market. The company profile chapter provides a selection of companies and organizations that arepioneering the use of specially designed digital and or wireless and cell phone-enabled testdevices for clinical diagnostic applications. The most advanced applications are available forglucose self-testing and the transmission of stained slide images in histology, microbiology andhematology for remote consultation with and analysis by an expert. The following companies are
  2. 2. profiled.•Accuster Technologies Pvt. Ltd.•AgaMatrix, Inc.•Alere•ARKRAY•ARUP Laboratories•Axxin•BBInternational•BIO-key International, Inc.•BodyTel Europe GmbH•California Institute of Technology (Caltech)•CellScope•CellScope Inc.•Clearbridge BioLoc Pte Ltd•Columbia University•DNAFORM•eSTI – (Electronic self-testing instruments)•Entra Health Systems•Freescale Semiconductor•Bill and Melinda Gates Foundation•Gene-Z•Genomic Health, Inc.•GenPrime, Inc.•Gentag Inc.•GlySens Incorporated•Harvard University Medical School•Heidelberger-Medical-Marketing GmbH (HMM GmbH)•HolGenTech Inc.•Holomic LLC (formerly Microskia)•Infopia Co Ltd•Intelligent Optical Systems, Inc.•Korea Advanced Institute of Science of Technology (KAIST)•Labonfoil Consortium•Leica Microsystems•Lifescan Inc.•Massachusetts General Hospital•MAVAND Solutions GmbH•MEDIWISS Analytic GmbH•Medtronic Inc.•MycroLab Pty Ltd.•NextLab
  3. 3. •Oasis Diagnostics•Oasis Scientific, Inc.•QIAGEN N.V.•QuantuMDx Group Limited•Sano Intelligence•Skannex•TelCare Inc.•Università Commerciale Luigi Bocconi•University of Arizona•University of Washington•X out TBThe companies selected are those that are pioneers in their field and that provide an overview ofthe innovations underway in cell phone-enabled diagnostics. The information presented in thisreport is derived on publicly available information sources such as company, government, andmedical organization reports. The analysis is based on the authors industry knowledge combinedwith literature searches and interviews with industry professionals and experts in the areas of POCtests, mobile health, decentralized healthcare and healthcare economics.The use of cell phone-enabled diagnostics is in the earlystages of development in both developedand developing world markets. Thereforethis market analysis is somewhat speculative.In spite ofthe buzz about the use of cell phone-enabled test devices inmHealth, there are so manycombinations of devices, applications and marketsthat the market is hard to define with precision.Current mHealth programs that use cell phones as part of thediagnostic process (with theexception of glucose self-testing) have beeninitiated as pilot projects in developing countries withlittle or no concreteplans for their continuation as fully funded and governmentsupportedhealthcare services.Further, since much of the current mHealth products aredelivered as smartphone apps andservices that are offered as part of a productoffering, it is difficult to estimate the size of theopportunity. Nevertheless, this report takes a bold lookinto the possibilities for cell phone-enabledtesting in the next five to tenyears.Get your copy of this report @http://www.reportsnreports.com/reports/190904-cell-phone-enabled-diagnostics-mhealth-applications-in-ivd.htmlMajor points covered in Table of Contents of this report includeTable of ContentsCHAPTER ONE: EXECUTIVE SUMMARYIntroductionScope and MethodologyMarket Trends
  4. 4. CHAPTER TWO: INTRODUCTIONBackgroundThe Case For Cell phone-Enabled DevicesConsulting From Far and WidePoint of ViewCHAPTER THREE: ENABLING TECHNOLOGIES AND COMMERCIALIZATIONARRANGEMENTSOverviewDefinition of Cell Phone-Enabled DiagnosticsAdvances in Microfluidics and BiosensorsThe Interface and Communication TechnologiesUC Davis InterfaceFrontline SMS MediciPhones, Blackberrys and PDAsAre Consumers Ready for mHealth?Physician and Payor OpinionCHAPTER FOUR: MARKET ANALYSIS - CELL PHONE-ENABLED DEVICESOverviewCell phone-Enabled Diagnostics For DiabetesScourge of DiabetesMarket Status of New Cell phone Glucose MonitorsRegulationDiagnostics in Cars?Cell phone-Enabled Rapid ImmunoassaysDecentralized TrendLateral Flow TestsFocus on Infectious DiseasesCell-Phone Enabled MicroscopyHistologyMicrobiologyHematologyCell Phone-Enabled Molecular TestsAmplificationNucleic Acid Lateral FlowMicrofluidic Cartridge-Based ApproachesThe Commercial Outlook for Cell phone-enabled Diagnostic Devices
  5. 5. CHAPTER FIVE: CONCLUSIONCHAPTER SIX: COMPANIES AND OFFERINGSAccuster Technologies Pvt. Ltd.AgaMatrix, Inc.AlereARKRAYARUP LaboratoriesAxxinBBInternationalBIO-key International, Inc.BodyTel Europe GmbHCalifornia Institute of Technology (Caltech)CellScopeCellScope Inc.Clearbridge BioLoc Pte LtdColumbia UniversityDNAFORMeSTI (Electronic self-testing instruments)Entra Health SystemsFreescale SemiconductorBill and Melinda Gates FoundationGene-ZGenomic Health, Inc.GenPrime, Inc.Gentag Inc.GlySens IncorporatedHarvard University Medical SchoolHeidelberger-Medical-Marketing GmbH (HMM GmbH)HolGenTech Inc.Holomic LLC (formerly Microskia)Infopia Co LtdIntelligent Optical Systems, Inc.Korea Advanced Institute of Science of Technology (KAIST)Labonfoil ConsortiumLeica MicrosystemsLifescan Inc.Massachusetts General HospitalMAVAND Solutions GmbHMEDIWISS Analytic GmbHMedtronic Inc.MycroLab Pty Ltd.
  6. 6. NextLabOasis DiagnosticsOasis Scientific, Inc.QIAGEN N.V.QuantuMDx Group LimitedSano IntelligenceSkannexTelCare Inc.Universita Commerciale Luigi BocconiUniversity of ArizonaUniversity of WashingtonX out TBList Of ExhibitsCHAPTER THREE: ENABLING TECHNOLOGIES AND COMMERCIALIZATIONARRANGEMENTSTable 3-1: Selected Cell phone Enabled Test DevicesCHAPTER FOUR: MARKET ANALYSIS - CELL PHONE-ENABLED DEVICESTable 4-1: Selected Cell phone-based Glucose MetersTable 4-2: Selected Wireless Enabled Glucose Monitors, 2011Table 4-3: Rapid Immunoassay Test Sales by Test Category 2011-2016, $ millionTable 4-4: Selected Cell phone-enabled Rapid Immunoassay InnovationsTable 4-5: Selected Molecular Tests And Platforms For Infectious DiseasesTable 4-6: Selected Cell Phone-Enabled Molecular Test Devices In DevelopmentContact: sales@reportsandreports.com for more information.